These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18292829)

  • 1. Increased expression of gap junction protein--connexin 32 in lymph node metastases of human ductal breast cancer.
    Kanczuga-Koda L; Sulkowska M; Koda M; Rutkowski R; Sulkowski S
    Folia Histochem Cytobiol; 2007; 45 Suppl 1():S175-80. PubMed ID: 18292829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gradual loss of functional gap junction within progression of colorectal cancer -- a shift from membranous CX32 and CX43 expression to cytoplasmic pattern during colorectal carcinogenesis.
    Kanczuga-Koda L; Koda M; Sulkowski S; Wincewicz A; Zalewski B; Sulkowska M
    In Vivo; 2010; 24(1):101-7. PubMed ID: 20133984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer.
    Kanczuga-Koda L; Sulkowski S; Lenczewski A; Koda M; Wincewicz A; Baltaziak M; Sulkowska M
    J Clin Pathol; 2006 Apr; 59(4):429-33. PubMed ID: 16567471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decreased expression of Cx32 and Cx43 and their function of gap junction intercellular communication in gastric cancer].
    Wu J; Zhou HF; Wang CH; Zhang B; Liu D; Wang W; Sui GJ
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):742-7. PubMed ID: 18396685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue microarray analysis of connexin expression and its prognostic significance in human breast cancer.
    Conklin C; Huntsman D; Yorida E; Makretsov N; Turbin D; Bechberger JF; Sin WC; Naus CC
    Cancer Lett; 2007 Oct; 255(2):284-94. PubMed ID: 17583422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of both MDR1 and MMP-2 genes in metastasized lymph node of invasive ductal breast cancer.
    Lu LS; Chen L; Ding WX; Li K; Wu JJ
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2037-43. PubMed ID: 23280016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
    Koda M; Sulkowska M; Kanczuga-Koda L; Tomaszewski J; Kucharczuk W; Lesniewicz T; Cymek S; Sulkowski S
    Oncol Rep; 2007 Jul; 18(1):113-9. PubMed ID: 17549355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of human prostate cancer cell growth by forced expression of connexin genes.
    Mehta PP; Perez-Stable C; Nadji M; Mian M; Asotra K; Roos BA
    Dev Genet; 1999; 24(1-2):91-110. PubMed ID: 10079514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of 6 common antigenic markers in invasive ductal breast carcinoma: potential clinical implications.
    Lialiaris TS; Kouskoukis A; Georgiou G; Tripsianis G; Fiska A; Giatromanolaki A; Chrisafi S; Sivridis E; Vamvakopoulou DN; Soutopoulou DO; Kiritsaka A; Athanassiou E; Lialios GA; Sotiriou S; Sidiropoulos A; Vamvakopoulos NC
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):106-11. PubMed ID: 20724920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connexin 32 induces pro-tumorigenic features in MCF10A normal breast cells and MDA-MB-231 metastatic breast cancer cells.
    Adak A; Unal YC; Yucel S; Vural Z; Turan FB; Yalcin-Ozuysal O; Ozcivici E; Mese G
    Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118851. PubMed ID: 32918981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.
    Popiela TJ; Sikora J; Klimek M; Basta P; Niemiec T; Dobrogowski J; Kotlarz A; Rudnicka-Sosin L; Dutsch-Wicherek M
    Neuro Endocrinol Lett; 2008 Aug; 29(4):443-6. PubMed ID: 18766141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.
    Koda M; Lenczewski A; Sulkowska M; Kanczuga-Koda L; Wincewicz A; Tomaszewski J; Sulkowski S
    Oncol Rep; 2007 Feb; 17(2):385-91. PubMed ID: 17203178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the expression of phosphorylated heat shock protein beta-1 with lymph node metastases of breast cancer.
    Kaigorodova EV; Zavyalova MV; Bogatyuk MV; Tarabanovskaya NA; Slonimskaya EM; Perelmuter VM
    Cancer Biomark; 2015; 15(2):143-50. PubMed ID: 25519015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion.
    Jonjic N; Mustac E; Dekanic A; Marijic B; Gaspar B; Kolic I; Coklo M; Sasso F
    Int J Surg Pathol; 2006 Oct; 14(4):306-11. PubMed ID: 17041193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of retinoblastoma protein in breast cancer metastases to sentinel nodes: evaluation of its role as a marker for the presence of metastases in non-sentinel axillary nodes, and comparison to p16INK4a.
    Grupka NL; Bloom C; Singh M
    Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):63-70. PubMed ID: 16540733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
    Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
    Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.